They found that concomitant miR-126-3p activation and miR-221-3p inhibition reduced lung cancer cell viability by inhibiting AKT, PIK3R2 and PTEN (Phosphatase And Tensin Homolog) signaling pathways (24). The gene discussed is AKT1; the disease is lung carcinoma.